The role of glutamine applied to critically ill patients with malignant tumor in enteral early postoperative

马金波,陈慧源,葛庆岗
DOI: https://doi.org/10.13455/j.cnki.cjcor.2014.02.35
2014-01-01
Abstract:Objective To investigate the clinical effects of glutamine applied to critically ill cancer patient at early postoperative. Methods Selected 110 cases of critically ill cancer surgery patients from January 2011 to December 2012 and divided them randomly into control group number and observation group. 55 patients of control group were treated with conventional standard nutritional support therapy,while observation group were treated with glutamine support therapy. Then application effects were observed. Results The comparative analysis of the application effects of the two groups showed that ALB, PAB and TRF of observation group and control group before treatment showed no significant statistically difference( P 0. 05),while PAB and TRF after treatment were statistically different( P 0. 05). IgA, IgG and IgM of the two groups before treatment showed no significant statistically difference( P 0. 05), while after treatment,IgG was statistically different( P 0. 05). BW,APACHE Ⅱ score and CRP of the two groups before treatment showed no significant statistically difference( P 0. 05),while APACHE Ⅱ score and CRP after treatment was statistically different( P 0. 05). The length of staying in ICU and postoperative infection complication rate of the patients in observation group were significantly lower than the control group,and the comparison data had significant difference( P 0. 05). Conclusions The glutamine applied to clinical critically ill cancer patients early after surgery has a better effect,which can effectively improve the nutritional status and immunity of patients and then improve clinical outcomes.
What problem does this paper attempt to address?